HPLC- An Andvanced Analytical Tool
Suyash Ingle*, Pratiksha B. Hajgude, Alfiya A. Mirza, Priyanka R. Patil, Nikita B. Harihar,
Pooja K. Yemul, Laxmi K. Patil
D.S.T.S. Mandal’s College of Pharmacy, Solapur - 413004, Maharashtra, India.
*Corresponding Author E-mail: suyashingle18@gmail.com
ABSTRACT:
A key component of analytical chemistry, High-Performance Liquid Chromatography (HPLC) is essential for the identification, separation, and quantification of substances in intricate mixtures. They can serve as the foundation for decisions on how to give medications to patients, and they are crucial to the development, production, and discovery of novel pharmaceutical products as well as a number of other human and animal studies. Validation of analytical techniques is necessary for both drug development and manufacturing, and these techniques are appropriate for their intended use. Pharmaceutical companies should have an overall validation policy that outlines the validation process in order to meet GMP regulations. The optimization of HPLC settings is the primary topic of this essay. A series of actions necessary for analysis and method development.
KEYWORDS: HPLC, Analytical Method of Validation, Pharmaceutical Analysis, Precision, Accuracy, Specificity.
INTRODUCTION:
Pharmaceuticals, environmental monitoring, and food analysis are just a few of the businesses that use High-Performance Liquid Chromatography (HPLC), a potent analytical method. HPLC technology has advanced dramatically, providing increased efficiency, speed, and sensitivity. It does have drawbacks, though, just as any analytical technique. This blog post will discuss some typical issues with HPLC, the development process, and validation.
I) Based on Mode of Separation:-
1.Normal phase chromatography uses a nonpolar (hydrophobic) mobile face and a polar (hydrophilic) stationary phase.
2. Reverse phase chromatography: the mobile phase is polyhydrophilic and the stationary phase is non-polar (hydrophobic). Compared to polar non-polar bonds, polar bonds and non-polar bonds have a higher affinity. Since drugs are typically hydrophilic, reverse phase chromatography is utilized more frequently.
1. Chromatography via Absorption
2. Chromatography by ion-exchange
3. Chromatography using ion pairs Ions in solution can be “paired,” or neutralized, and separated as an ion pair on a reversed-phase column using this type of chromatography. In order to retain the ion pair on a reversed-phase column, ion- pairing agents are typically ionic compounds with a hydrocarbon chain that adds a specific hydrophobicity.
4. The chromatography of gel permeation. There is no appealing interaction between the solute and stationary phase in this kind of chromatography. A porous gel separates the molecules based on size as the liquid or gaseous phase passes through it.
5. Chromatography by Affinity
6. Chromatography of chiral III. USING ELUTION TECHNIQUE AS A BASIS A separation using a single solvent or solvent mixture with a consistent composition is known as isocratic elution.
1) The Pump:
The development of HPLC led to the development of the pump system. The positioned in the most upper stream of the liquid chromatography system and generates a flow of eluent. From the solvent reservoir into the system.
An injector is placed next to the pump. The simplest method is to use a syringe, and the sample is introduced to the flow of eluent. The most widely used injection method is based on sampling loops. The use of the autosampler (auto-injector) system is also widely used that allows repeated injections in a set scheduled-timing.
3) Column:
The separation is performed inside the column. The recent columns are often prepared in a Stainless steel housing, instead of glass columns. The packing material generally used silica or polymer gels compared to calcium carbonate. The eluent used for LC varies from acidic to basic solvents. Most column housing is made of stainless Steel since stainless is tolerant towards a large variety of solvents.
4) Detector:
Separation of analyte is performed inside the column, whereas a detector is used to observe The obtained separation. The composition of the eluent is consistent when no analyte is present. While the presence of analyte changes the composition of the eluent. What detector does is to Measure these differences. This difference is monitored as a form of an electronic signal. There Are different types of detectors available.
The change in eluent detected by a detector is in the form of an electronic signal, and thus it is Still not visible to our eyes. In older days, the pen (paper)-chart. Recorder was popularly used. Nowadays, a computer-based data processor (integrator) is more common.
The eluent used for LC analysis may contain gases such as oxygen that are non-visible to our Eyes. When gas is present in the eluent, this is detected as noise and causes an unstable Baseline. Degasser uses special polymer membrane tubing to remove gases. The numerous polymer tube has tiny pores on its surface that let air through but keep liquid from passing through.
The column temperature frequently has a significant impact on the LC separation. Maintaining constant temperature conditions is crucial for reproducible results. Additionally, higher temperatures (50 to 80°C) can yield greater resolutions for particular analyses, such as those involving sugar and organic acid. As a result, columns are typically stored within column ovens, also known as column heaters.
The following steps were included in the HPLC method of development:
1. Investigating Finding the ideal combinations for a successful separation by screening different column and eluent conditions.
2. Improving separation conditions through alternative testing to attain optimal resolution, speed, and repeatability.
3. Testing for robustness Assessing the effects of altering the separation method’s parameters on the outcomes.
4. Verification Assessing if the developed analytical method is appropriate for the intended use.
· Bioanalytical method validation:
Validation is mandatory by the regulatory agencies. The main objective of method validation is to demonstrate the reliability of a particular method developed for the quantitative determination of an analyte in a specific Biological matrix [6].
Full validation is necessary when developing and implementing an analytical method for Analysis of a new drug entity, when developing and implementing a bioanalytical method for The first time and when an existing assay method is modified metabolites are added to an Existing assay for quantification of a drug.
Partial validations are modifications of existing validated bioanalytical methods. Determination to a nearly full validation. Bioanalytical method changes that require partial validation are Method transfers between laboratories or analysts Modification of analytical Methodology (e.g., change in detection systems), addition of different anticoagulant in harvesting biological fluid changes in matrix within the same species (e.g., human plasma to human urine), alteration of sample processing procedures Changes in species within matrix (eg., rat plasma to mouse plasma).
Cross-validation compares two bioanalytical techniques for the same medication. The updated bioanalytical method is the comparator, while the original, certified bioanalytical method is the reference. When two or more bioanalytical techniques are employed to produce data for a single study, cross validation is necessary.
Cross-validation using spiked matrix standards and subject samples should be carried out to establish inter-laboratory reliability when sample analyses within a single research are carried out at multiple locations of different laboratories. Additionally, cross-validation should be taken into account when data is generated utilizing several analytical All factors affecting the quality of the data, including selectivity, are included in the fundamental parameters for the validation of a chemical assay. Linearity, recovery, accuracy, and precision. Limit of detection (LOD), lower limit of quantification (LLOQ), stability, reproducibility, specificity and calibration model etc.
The ability of an analytical technique to distinguish and measure the analyte in the presence of other components in the sample is known as selectivity. Endogenous matrix components, metabolites, breakdown products, and, in the case of the study, concurrent xenobiotic medications are examples of potential interfering chemicals in a biological matrix. As well as additional exogenous Analyzing blank samples of the relevant biological matrix from a minimum of six sources is necessary for selectivity. Selectivity should be guaranteed at LLOQ, and each blank should be examined for interference from other drugs.
The degree to which the mean test findings produced by an analytical procedure closely resemble the actual value (analyte concentration) is known as its accuracy. Using a minimum of six determinations per concentration, accuracy should be assessed for at least three concentrations within the anticipated concentration range. With the exception of LLOQ, where it shouldn’t vary by more than 20%, the mean should be within 15% of the actual value. Accuracy is gauged by this mean’s departure from the actual value.[4]
When an analytical procedure is done repeatedly to several aliquots of a single homogenous volume of biological matrix, the precision of the method is defined as the proximity of individual measures of an analyte. A minimum of three concentrations within the anticipated concentration range, with five determinations per concentration, should be used to gauge precision. No more than 15% of the coefficient shall be exceeded by the precision calculated at each concentration level of variation (CV), with the exception of the LLOQ, which shouldn’t be more than 20% of the CV.
In an assay, an analyte’s recovery is determined by comparing the detector response for the actual concentration of the pure authentic standard with the detector response for a quantity of the analyte introduced to and extracted from the biological matrix.
Three concentrations (low, medium, and high) should be used for recovery tests, and unextracted standards representing 100% recovery should be used. Analyte recovery does not have to be 100%, although the degree of recovery Additionally, an internal standard ought to be repeatable, accurate, and consistent.
This refers to the relationship between the instrument's response and known analyte concentrations. The ability of the procedure to produce test findings that are exactly proportionate to the analyte concentration in the sample is measured by linearity.
It is the connection between known analyte concentrations and experimental response values. The same biological matrix used for the intended investigation should be used to create a calibration curve by spiking the matrix with known analyte concentrations. If there aren’t enough blank samples available, for example. 0.9% NaCl can be utilized as a calibration matrix for cerebrospinal fluid, and the results of the two matrices should be compared. 20% of the LLOQ deviates from actual concentrations, while 15% of standards other than LLOQ deviate from genuine values. Including the LLOQ and the calibration standard at the maximum concentration, at least four of the six non-zero standards should satisfy the aforementioned requirements.
Under the specified experimental conditions, it is the smallest amount of analyte in a sample that can be detected but not always quantified.
It is the smallest concentration of analyte in a sample that can be identified but must be quantified with sufficient precision and accuracy under the specified experimental circumstances.
· Analysis that is qualitative Verifying a compound’s purity and looking for impurities Analyzing quantitatively
· Environmental applications
· Forensic applications
· Biochemical separations
· Drug mixture analysis
· Drug isolation and identification
· Drug and compound mixture isolation and identification
· Biopharmaceutical and pharmacokinetic studies,
· Stability studies,
· Compound purification, biotech and food analysis.
· Pharmaceutical applications –
HPLC is essential to the pharmaceutical sector, especially for quality assurance, medication development, and regulatory compliance. It is frequently used to assess the stability, potency, and purity of medication formulations. HPLC techniques are crucial for impurity profiling and degradation investigations, which are necessary to guarantee the efficacy and safety of medications.
Environmental Monitoring:
For the analysis of pollutants, poisons, and trace contaminants in soil, water, and air, HPLC is an essential instrument in environmental science. It makes it possible to measure industrial chemicals, pesticides, and herbicides, guaranteeing adherence to environmental safety regulations.
Food and Beverages:
The food and beverage industry makes substantial use of HPLC to guarantee the authenticity, quality, and safety of its products. It is used to identify contaminants such mycotoxins, heavy metals, and food allergies as well as to test flavorings, preservatives, and nutritional components. HPLC-based techniques are essential for ensuring adherence to food safety laws and safeguarding the health of consumers. Sector The food and beverage industry makes substantial use of HPLC to guarantee the authenticity, quality, and safety of its products. It is used to identify contaminants such mycotoxins, heavy metals, and food allergies as well as to test flavorings, preservatives, and nutritional components. HPLC-based techniques are essential for ensuring adherence to food safety laws and safeguarding the health of consumers.
1. Sample Preparation Challenge:
In HPLC analysis, sample preparation is frequently laborious and prone to mistakes. Poor chromatographic findings and longer analytical times can come from inaccurate sample preparation.
2. Column Selection and Maintenance Challenge:
Because many factors such as stationary phase, column diameters, and particle size can effect separation, choosing the appropriate column for your HPLC analysis can be difficult. Effectiveness and resolution. Furthermore, poor performance may result from column deterioration over time.
3. Mobile Phase Compatibility Challenge:
To get the best separation, the right mobile phase must be chosen. Nevertheless, some analytes might not work well with conventional mobile phases, which could result in poor peak shape and drift in retention time.
4. Detector Sensitivity Challenge:
In complex samples, low detector sensitivity may restrict the measurement of trace-level analytes.
HPLC is used widely, although it has drawbacks such high operating expenses, a need for qualified staff, and complicated equipment maintenance. Problems including matrix effects, co-elution, and peak broadening might arise when managing varied sample matrices, necessitating careful method optimization.
The future of High-Performance Liquid Chromatography (HPLC) appears bright due to developments in a number of scientific domains. Here are some important prospects for the future:
1. Portability and Miniaturization: -The creation of small and lightweight HPLC systems for on-site examination in forensic, environmental, and healthcare settings.
2. Integration of Automation and AI: - AI-powered chromatographic condition optimization Automated compound identification, peak detection, and data analysis.
3. Sustainable and Eco-Friendly HPLC: - The use of environmentally friendly solvents and lower solvent usage (e.g., water-based systems, supercritical fluid chromatography). Energy-efficient devices to reduce the impact on the environment.
4. Developments in Column Technology: - Creation of high-resolution, ultra-fast columns (such as monolithic, sub-2 µm particle columns). Enhanced stationary phase to increase the effectiveness of separation
5. Hyphenated methods:-High-throughput and accurate analysis can be achieved by combining with mass spectrometry (HPLC-MS/MS). Integration with additional methods for thorough profiling, such as UV-Vis and NMR.
6. Use in Personalized Medicine in Biopharmaceuticals: - Better examination of intricate biological compounds, such as peptides and monoclonal antibodies. Improved biomarker identification and therapeutic medication monitoring.
7. Increased Speed and Sensitivity: - The use of ultra-high-performance liquid chromatography (UHPLC) is expanding. HPLC’s future rests in its capacity to develop alongside new technologies, becoming more effective, sustainable, and broadly applicable across a range of scientific fields.
In conclusion, HPLC has continuously been a fundamental component of analytical science, propelled by developments in technology, validation, and technique development. It is essential in a variety of fields, such as clinical diagnostics, food safety, environmental monitoring, and medicines, because to its accuracy, adaptability, and versatility. Although it has its share of difficulties, high-performance liquid chromatography is a flexible and essential analytical method. Analysts can improve the effectiveness and dependability of their HPLC analyses by tackling these issues with creative solutions, such as automation, sophisticated column technology, sensitive detectors, and data processing software. An advanced analytical tool, HPLC has a number of prospects, trends, and predictions for the upcoming ten years.
1. Arpino, Patrick. Combined liquid chromatography-mass spectrometry. Part I. Coupling by Means of a moving belt Interface”. Mass Spectrometry Revieves 1989; 8:35Doi:10.1002/mas.1280080103
2. Gupta V, Jain AD, Gill NS, Gupta K Development and validation of HPLC method a review.International ResearchJournal of Pharmaceutical and Applied Sciences. 2012; 2(4): 17-25
3. Panchumarthy Ravisankar. A Review on Step-by-Step Analytical Method Validation. Journal Of Pharmacy. www.iosrphr.org Volume 5, Issue 10 (October 2015). PP. 07-19
4. Sonia K, Nappinnai M. Development and validation of HPLC and UV-visible Spectrophotometric method for the pharmaceutical dosage form and biological fluid review. European Journal of Biomedical and Pharmaceutical Sciences. 2016; 3(3): 382-391
5. Vibha Gupta et al. Development and validation of HPLC method a review, International Research Journal of Pharmaceutical and Applied Sciences. 2012; 2(4):17-25
6. Santosh Kumar Bhardwaj et al. A Review: HPLC Method Development and Validation. International Journal of Analytical and Bioanalytical Chemistry. Accepted 20 November 2015
7. Method Development: A Guide to Basics Quantitative C Qualitative HPLC, LC, GC Chromacademy.
8. Rajesh Y. Chaudhari, Sachin S. Rane, Mahesh S. Nemade. A Validated RP-HPLC Method Development and Validation for The Simultaneous Estimation of Nebivolol and Valsartan in Bulk Drug and Pharmaceutical Dosage Form. International Journal of Technology. 2022; 12(2): 25-1.
9. ICH Topic Q 2 (R1) Validation of Analytical Procedures: Text and Methodology Validation of Chromatographic Methods. Development and validation of a simple reverse Dphase HPLC-UV method for determination of oleuropein in olive leaves Fuad Al- Rimawi Elsevier, Science Direct Journal of Food and Drug Analysis. 2014; 22: 285-289
10. HPLC Columns. Theory, Technology and Practice. Uwe D. Neue, Wiley-VC Principles of Instrumental Analysis”, 5th edition, Harcourt Publishes Int Company. Skoog. Holler and Niernan, Chapter 28, p.726-766.
11. Handbook of HPLC, Vol.78, by Elena Katz et al. Marcel Dekker Inc Instrumental Methods of Chemical Analysis”, 5th Edition, Galen W. Ewing, McGraw Hill Book Company 1988.
12. Analytical Method Development and Method Validation for the Simultaneous Estimation of Metformin hydrochloride and Pioglitazone hydrochloride in Tablet Dosage Form by RP-HPLC. Asian J. Pharm. Ana. 2012; 2(3): 85-89.
13. “HPLC in Pharmaceutical Industry”, Fong and Long, Marcel Dekker Series “Instrumental Method of Chemical Analysis” by Chatwal Anand, Himalaya Publishing House, p.no.615-623.
14. “Practical Pharmaceutical Chemistry, 4th edition, Part 2, by Beckett and Stenlake, CBS Publishers and Distributors, P.No.157-174.
15. Govt. of India, Ministry of Health and Family Welfare. Vol. 2. Delhi: Publication by Controller Of Publication; 2007. Indian Pharmacopoeia; pp. 484-554.
16. Jadhav Ankush P., Datar P.A., Shete R.V. Analytical Method for Determination of Thiocolchicoside in marketed Pharmaceutical Preparation: A Review. Int. J. Tech. 2019; 9(2): 45-53.
17. Chinmaya Keshari Sahoo, Muvvala Sudhakar, D. Venkata Ramana, K. Satyanarayana, Kanhu Charan Panda. Validation of Analytical Procedures- A Review. Asian J. Pharm. Ana. 2018; 8(2): 109-116.
18. United States Pharmacopoeia 29 NF 24, Published on the Recommendation of the Medicines
19. J.D. Stafford, T.D. Maloney, D.P. Myers, J.M. Clintron, D.C. Castle, A systematic approach to Development of liquid chromatographic impurity methods for pharmaceutical analysis, J. Pharm. Biomed. Anal. 2011; 56: 280-292.
20. L. Yan, G.J. Terfloth, A.S. Kord, A systematic approach to RP-HPLC method development in a Pharmaceutical QhD environment, Am. Pharm Anal. 2009; 12: 92-95.
21. Akhilesh Gupta, Jaydeep Singh Yadav, Swati Rawat, Mayuri Gandhi. Method Development and Hydrolytic Degradation Study of Doxofylline by RP-HPLC and LC-MS/MS. Asian J. Pharm. Ana. 2011; 1(1): 14-18.
22. Akhilesh Gupta, Jaydeep Singh Yadav, Swati Rawat , Mayuri Gandhi. Method Development and Hydrolytic Degradation Study of Doxofylline by RP-HPLC and LC-MS/MS. Asian J. Pharm. Ana. 2011; 1(1): 14-18.
23. Ganesh Akula, P. Rajashekar, Rangu Nirmala, K. Kanakaiah, A. Jaswanth. Method Development and Validation for Simultaneous Estimation of Omeprazole and Ofloxacin by using RP-HPLC. Asian J. Pharm. Ana. 2018; 8(3): 153-156.
24. Khushboo Patel, Dhara Patel, Jaya Dwivedi, Priyanka Newal, Dhananjay Meshram. A Review on Analytical Techniques for Estimation of Anti Cholinergic Drug: Glycopyrronium Bromide. Asian J. Pharm. Ana. 2017; 7(4): 239-242.
25. Mayur S. Jain, Shashikant D. Barhate, Bhushan P. Gayakwad. Cefadroxil: A Review of Analytical Methods. Asian J. Pharm. Ana. 2018; 8(1): 58-61.
26. Gandla Kumaraswamy, Gandla Lalitha, N. Ravindra, K.B. Pradeesha. Simultaneous Estimation of Amlodipine, Atenolol and Hydrochlorothiazide in Bulk and Tablet Dosage Form by RP-HPLC Method. Asian J. Pharm. Ana. 2014; 4(4): 131-136.
27. Sobhy M. El-Adl, Mohamed El. Hossinny El. Sadek, Marwa Hamdy Hassan. HPLC Determination of Cefepime, Cefotaxime and Cefoperazone in Bulk and Dosage Forms. Asian J. Pharm. Ana. 2014; 4(4): 168-173.
|
Received on 17.03.2025 Revised on 12.05.2025 Accepted on 17.06.2025 Published on 20.06.2025 Available online from June 30, 2025 International Journal of Technology. 2025; 15(1):24-30. DOI: 10.52711/2231-3915.2025.00005 ©A and V Publications All right reserved
|
|
|
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License. |
|